Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection.

Authors: Hall WW, Ishak R , Zhu SW, Novoa P, Eiraku N, Takahashi H, Ferreira Mda C, Azevedo V, Ishak MO, da Costa Ferreira O, Monken C, Takeshi K
Publication Year: 1996
Last Updated: 2010-01-21 08:14:08
Journal: Journal of Acquired Immune Deficiency Syndromes
Keywords: Human T-lymphotropic virus type II; urban areas; neurological disorders

Short Abstract:

Human T lymphotropic virus, type II (HTLV-II), infection has been shown to be endemic in a number of American Indian populations, and high rates of infection have also been documented in intravenous drug abusers in urban areas throughout the world.  Although the role of HTLV-II in human disease has yet to be clearly defined, there is accumulating evidence that like HTLV-I, infection may also be associated with rare lymphoproliferative and neurological disorders.  In this article we review and summarize the epidemiology, molecular properties and clinical features of HTLV-II infection.

Abstract: Human T lymphotropic virus, type II (HTLV-II), infection has been shown to be endemic in a number of American Indian populations, and high rates of infection have also been documented in intravenous drug abusers in urban areas throughout the world. Although the role of HTLV-II in human disease has yet to be clearly defined, there is accumulating evidence that like HTLV-I, infection may also be associated with rare lymphoproliferative and neurological disorders. In this article we review and summarize the epidemiology, molecular properties and clinical features of HTLV-II infection. 

Members Only Download:

Source: Link to Original Article.
Funding: These studies were supported by Grant CA64038 from the NIH/NCI,
Code: 214
Source: Na